Soybean oil is one of the most common ingredients in the American diet, showing up as a cooking oil and as a component of countless processed foods. A mouse study from the University of California, Riverside has now traced a possible mechanism connecting the fat it contains to weight gain and metabolic changes, though the work stops well short of proving the same thing happens in people. The key finding is not that the oil itself is uniquely dangerous, but that a molecule the body makes while breaking it down may be doing most of the damage.
A three-diet mouse experiment isolates linoleic acid’s role
Researchers fed groups of mice one of three diets for several months: a high-fat diet rich in soybean oil, which is high in linoleic acid; a high-fat diet built on coconut oil, which is low in linoleic acid; or a low-fat diet. Mice on the soybean oil diet gained significant weight, consistent with earlier work from the same lab going back to 2015 that first found soybean oil more likely to cause weight gain in mice than coconut oil. Soybean oil consumption in the United States has climbed roughly five-fold over the past century, from about 2 percent of total calories to nearly 10 percent today, driven largely by its use in cooking and processed food manufacturing.
A single liver protein swap blocked weight gain on an identical diet
The twist in the experiment involved a subset of mice that were genetically engineered to produce an alternate version of a liver protein called HNF4α, which influences hundreds of genes tied to fat metabolism. Despite eating the exact same high-fat soybean oil diet as the unmodified mice, these genetically altered mice did not gain the expected weight. Their livers also showed smaller fat droplets under microscopic staining and displayed enhanced mitochondrial function, the cell structures that generate energy, which may help explain why they resisted the weight gain seen in regular mice on the same diet.
Oxylipins, not the oil itself, appear to drive the effect
The research team traced the difference to oxylipins, active molecules produced when the body processes linoleic acid and a related fat called alpha-linolenic acid, both abundant in soybean oil. The genetically altered mice had significantly lower levels of two enzyme families responsible for converting these fats into oxylipins, and those enzyme families are highly conserved across mammals, including humans. “We’ve known since our 2015 study that soybean oil is more obesogenic than coconut oil,” said cell biologist Frances Sladek of UC Riverside. “But now we have the clearest evidence yet that it’s not the oil itself, or even linoleic acid. It’s what the fat turns into inside the body.”
A low-fat diet produced similar oxylipin levels without obesity
One finding complicates a simple oxylipin-causes-obesity story: mice on the low-fat diet had oxylipin levels similar to those in the mice that became obese on soybean oil, yet the low-fat mice did not gain weight. That suggests the presence of these molecules alone is not sufficient to cause obesity, and that other factors tied to a high-fat diet have to be present alongside elevated oxylipins for the weight gain to occur. The researchers, whose work appears in the Journal of Lipid Research, say the exact combination of conditions required is still being worked out. Oxylipins have separately been associated with inflammation in other research, and the team is now examining whether the same weight-gain pathway shows up with other oils high in linoleic acid, including corn, sunflower and safflower oil.
Liver measurements, not blood tests, tracked with body weight
Only oxylipin levels measured in the liver correlated with body weight in the study; oxylipin levels in the blood did not track with weight at all. That distinction matters because it means a routine blood test would likely miss the metabolic signal the researchers identified, since the relevant activity was happening in liver tissue rather than circulating in the bloodstream. Biomedical scientist Sonia Deol, the study’s corresponding author, said the finding “may be the first step toward understanding why some people gain weight more easily than others on a diet high in soybean oil,” noting that both versions of the HNF4α protein exist in humans, with the protective form typically appearing only during chronic illness or metabolic stress.
The findings come from mice, not people, and no human trials are planned
Every result described here comes from a controlled mouse experiment, and the researchers have no human trials underway or scheduled. Mouse metabolism differs from human metabolism in significant ways, and the specific genetic variant that blocked weight gain in this experiment is not something anyone can currently test for or replicate through diet alone. Deol described soybean oil as “not inherently evil,” while Sladek compared the pace of public awareness to the century-long gap between early tobacco-cancer research and warning labels on cigarettes, framing the study as an early step in a much longer scientific process rather than a final verdict on the ingredient.
This article was produced with the assistance of AI and reviewed by Morning Overview editors prior to publication.
More from Morning Overview
